CUSIP: 45780V102
Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,687,952
-
Share change
-
+9,687,952
-
Total reported value
-
$52,499,000
-
Price per share
-
$5.42
-
Number of holders
-
15
-
Value change
-
+$52,499,000
-
Number of buys
-
15
Quarterly Holders Quick Answers
What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45780V102:
Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q1 2015
As of 31 Mar 2015,
INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,687,952 shares.
The largest 10 holders included
Devon Park Associates, LLC, RHO CAPITAL PARTNERS INC, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, Pentwater Capital Management LP, SPHERA FUNDS MANAGEMENT LTD., Telemetry Investments, L.L.C., ALLIANCEBERNSTEIN L.P., Spark Investment Management LLC, and PURA VIDA INVESTMENTS, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.